Metformin Biodistribution: A Key to Mechanisms of Action?

Elias Sundelin, Jonas Brorson Jensen, Steen Jakobsen, Lars C Gormsen, Niels Jessen

The Journal of clinical endocrinology and metabolism 2020 Nov 01

filter terms:

Metformin has undisputed glucose-lowering effects in diabetes and an impressive safety record. It has also shown promising effects beyond diabetes, and several hundred clinical trials involving metformin are currently planned or active. Metformin targets intracellular effectors, but exactly which remain to be established, and in an era of precision medicine, an incomplete understanding of mechanisms of action may limit the use of metformin. Distribution of metformin depends on specific organic cation transporter proteins that are organ- and species-specific. Therefore, target tissues of metformin can be identified by cellular uptake of the drug, and exploring the biodistribution of the drug in humans becomes an attractive strategy to assist the many investigations into the mechanisms of action of metformin performed in animals. In this review, we combine the emerging evidence from the use of 11C-labeled metformin in humans to discuss metformin action in liver, intestines, and kidney, which are the organs with the most avid uptake of the drug.

Citation

Elias Sundelin, Jonas Brorson Jensen, Steen Jakobsen, Lars C Gormsen, Niels Jessen. Metformin Biodistribution: A Key to Mechanisms of Action? The Journal of clinical endocrinology and metabolism. 2020 Nov 01;105(11)